Physiological MplW514L expression in hematopoietic stem cell causes an essential thrombocythemia and progressive myelofibrosis
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci199690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Shujing Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Receptors, Thrombopoietin, Thrombocythemia, Essential, Primary Myelofibrosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Shandong Province in China, Program of Innovation Improvement of Small and Medium-sized Enterprises of Shandong Province in China.
Abstract (Originalsprache)
Typ515 (W515) mutations in the protein MPL are one of the key driver mutations promoting BCR-ABL-negative myeloproliferative neoplasms (MPNs), but, to our knowledge, their effects on hematopoietic stem cells (HSCs) and MPN-related hematological abnormalities have not been studied in physiological contexts. Here, we established a MplW514L knock-in mouse model, which largely mimics human MPLW515L mutation during hematopoiesis. The mutant mice developed an essential thrombocythemia–like (ET-like) MPN phenotype, displaying excess megakaryopoiesis and thrombocytosis and progressive myelofibrosis. Mechanistically, we observed that the MplW514L-conditioned HSC compartment had a unique disease-initiating capacity; however, it did not exhibit a obvious advantage of competitive repopulation over the WT control. Notably, single-cell analysis and flow cytometry profiles support that MplW514L expression led to a significant expansion of megakaryocyte-biased stem cell fate within the HSC pool. Finally, JAK2 inhibitor treatment phenotypically alleviated the ET signs but failed to eliminate the disease-initiating HSCs. These findings underscore the etiology of physiological expression of the MPLW515L mutation in HSCs and also provide a valuable in vivo model to evaluate potential therapeutic options for patients with MPLW515L-positive MPN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine.
- Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences.
- NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, and.
- Department of Pharmacology, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.
- State Key Laboratory of Experimental Hematology, Tianjin Key Laboratory of Inflammatory Biology, Department of Pharmacology, School of Basic Medical Science, Tianjin Medical University, Tianjin, China.
- The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China.
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Shandong Province in China
- Program of Innovation Improvement of Small and Medium-sized Enterprises of Shandong Province in China
- National Natural Science Foundation of China
Zitieren
APA
Zhang, S., Liu, J., Li, Y., Wang, Y., Wang, L., Xu, M., Li, Y., Dong, G., Wang, S., Li, Y., Cai, Z., & Zhao, B. (2026). Physiological MplW514L expression in hematopoietic stem cell causes an essential thrombocythemia and progressive myelofibrosis. Journal of Clinical Investigation. https://doi.org/10.1172/jci199690
Vancouver
Zhang S, Liu J, Li Y, Wang Y, Wang L, Xu M, et al. Physiological MplW514L expression in hematopoietic stem cell causes an essential thrombocythemia and progressive myelofibrosis. Journal of Clinical Investigation. 2026. doi:10.1172/jci199690
BibTeX
@article{Zhang2026,
author = {Zhang, Shujing and Liu, Jingjing and Li, Yuan and Wang, Yi and Wang, Lingling and Xu, Miaomiao and Li, Yanxia and Dong, Ge and Wang, Shanshan and Li, Yanmei and Cai, Zhigang and Zhao, Baobing},
title = {Physiological MplW514L expression in hematopoietic stem cell causes an essential thrombocythemia and progressive myelofibrosis},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci199690}
}
EUVIMED